AMNEAL PHARMACEUTICALS INC's ticker is and the CUSIP is 03168L955. A total of 3 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | 0.0% | 400 | -50.0% | 0.00% | – |
| Q1 2023 | $1 | – | 800 | +300.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 200 | -97.9% | 0.00% | – |
| Q2 2022 | $30,000 | -96.9% | 9,700 | -95.8% | 0.00% | -100.0% |
| Q1 2022 | $966,000 | -18.5% | 231,800 | -6.3% | 0.00% | 0.0% |
| Q4 2021 | $1,185,000 | +4640.0% | 247,400 | +5054.2% | 0.00% | – |
| Q3 2021 | $25,000 | +4.2% | 4,800 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | -85.1% | 4,800 | +1900.0% | 0.00% | – |
| Q1 2021 | $161,000 | +94.0% | 240 | +31.1% | 0.00% | – |
| Q4 2020 | $83,000 | -35.2% | 183 | -44.5% | 0.00% | – |
| Q3 2020 | $128,000 | -18.5% | 330 | 0.0% | 0.00% | – |
| Q2 2020 | $157,000 | +282.9% | 330 | +179.7% | 0.00% | – |
| Q1 2020 | $41,000 | -55.4% | 118 | -38.2% | 0.00% | – |
| Q4 2019 | $92,000 | -31.3% | 191 | -58.8% | 0.00% | – |
| Q3 2019 | $134,000 | +318.8% | 464 | +931.1% | 0.00% | – |
| Q2 2019 | $32,000 | +14.3% | 45 | +125.0% | 0.00% | – |
| Q1 2019 | $28,000 | -31.7% | 20 | -35.5% | 0.00% | – |
| Q4 2018 | $41,000 | -82.8% | 31 | -71.3% | 0.00% | -100.0% |
| Q3 2018 | $239,000 | +29.2% | 108 | -4.4% | 0.00% | 0.0% |
| Q2 2018 | $185,000 | – | 113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 448,200 | $905,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 200 | $0 | 0.00% |